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CASE REPORT
Hepatocellular adenoma (HA) is a benign hepatic lesion that predominantly occurs in young women. Most
hepatocellular carcinomas (HCC) arise in a cirrhotic liver during the fifth or sixth decades. There have been
several reported cases of HCC developing from HA in female patients. However, there are rare cases about HCC
arising in HA in a non-cirrhotic male patient. We have recently encountered a 53-year-old man who had a liver
mass in a non-cirrhotic liver, and the liver mass was compatible with HA on the pre-operative computed
tomography. The mass was completely resected and the histopathology revealed a focus of HCC arising in HA. We
report here on this case along with a brief review of the relevant literature. (Korean J Intern Med 2009;24:147-152)
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INTRODUCTION
Hepatocellular adenoma (HA) is a rare benign liver
tumor that most frequently occurs in women. This
neoplasm makes up two percent of all hepatic tumors. It
occurs in non-cirrhotic liver parenchyme and it has an
estimated prevalence of 1-3 per 100,000 young women
with a long-standing history of oral contraceptive use [1].
HA typically develops in the setting of hormonal or
metabolic abnormalities that stimulate hepatocyte
proliferation. There have been many reports about the
relationship between oral contraceptives and HA, and
this relationship was first described by Banum, et al. [2].
However, the precise mechanism for this relationship has
not yet been determined [3,4]. Besides oral contraceptives,
there are other predisposing factors for HA such as
anabolic steroids, diabetes mellitus, beta-thalassemia
and glycogen storage disease type 1 [5-7]. Although the
pathophysiology is not yet fully known, malignant
transformation of HA into hepatocellular carcinoma
(HCC) has been reported [8-10]. There are about 12
reported cases of malignant transformation in women
and one case in a man from other countries in the medical
literature [11,12]. However, only one case of HCC arising
in HA in a man has been reported in Korea [13]. We report
here on a case of HCC within HA in a non-cirrhotic male
patient.
CASE REPORT
A 53-year-old man visited our hospital for evaluation
of his vague abdominal discomfort. On the initial visit,
the patient complained of having right upper quadrant
discomfort and fatigue for the past 4 months. His body
weight was the same over the recent years. His past
medical history was unremarkable and he had no history
of drug or alcohol abuse. The physical examination did notreveal any abnormal findings except for hoarseness due to
heavy smoking (20 pack-years). The laboratory findings
were as follows: white blood cell count 4,700/mm
3, hemo-
globin 13.8 g/dL, platelet count 270,000/mm
3, aspartate
aminotransferase 41 IU/L, alanine aminotransferase 38
IU/L, alkaline phosphatase 105 IU/L, gamma-glutamyl
transpeptidase 46 IU/L and prothrombin time 100%.
Serological tests for hepatitis B surface antigen (HBsAg),
the antibody to the core antigen (anti-HBc), antibody to
the hepatitis C virus (anti-HCV) and the markers for
autoimmune liver disease were all negative and the serum
levels of alpha-fetoprotein (AFP) and prothrombin
induced by vitamin K deficiency or antagonist-II (PIVKA-
II) were normal. Abdominal ultrasonography revealed an
approximately 6.0 cm sized exophytic bulging mass that
was focally cystic and heterogenous in the inferior portion
of the right hepatic lobe (Fig. 1). The unenhanced image of
multiphase helical computed tomography (CT) revealed a
heterogenous solid exophytic hepatic mass with intra-
tumoral hemorrhage (Fig. 2A). On the arterial and portal
phases, a well-defined encapsulated mass with heteroge-
nous contrast enhancement was noted (Fig. 2B and 2C).
On the delayed phase, there was no definite appearance of
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Figure 2. Liver dynamic computed tomography findings. (A) On the non-contrast phase, the heterogenous density and fluid-fluid level
suggested intratumoral hemorrhage (white arrow). Fat density is not evident. (B) On the arterial phase, heterogenous contrast enhancement
was noted. (C) On the portal phase, the heterogenous contrast enhancement of the tumor persisted. (D) Some portion of the capsule was
enhanced on the delayed phase.
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Figure 1. Abdominal ultrasonography revealed an approximately
6 cm sized exophytic bulging mass that was focally cystic and
heterogenous in the inferior portion of the right lobe of the liver.
Awashout (Fig. 2D). Based on the radiological findings, the
patient was diagnosed with HA and so wedge resection of
the hepatic mass was carried out. The resected specimen
was a solitary bulging round mass that measured 4.5 cm
in diameter. The cut section was well-demarcated, dark
reddish and lobulated. Further, a partly hemorrhagic
nodular feature was identified. A small round yellowish
white nodule (about 1.0×0.9 cm) was noted within the
mass (Fig. 3). The surrounding liver tissue revealed no
fibrosis or cirrhotic change. Microscopic examination of
the specimen revealed the typical feature of hepatocellular
adenoma, including liver cell cords that were one to two
cell thick, a slightly increased cell density and peliosis (Fig.
4A). In the adenoma, a small round well-demarcated
lesion that showed the appearance of the typical tra-
becular type HCC was noted, and so this gave a pattern
of a nodule within a nodule (Fig. 4B). The HCC area
showed liver cell cords that were three or more cells thick,
pseudoacinar formation and nuclear atypia (Edmondson-
Steiner grade II) (Fig. 4C). The postoperative course was
uneventful; the patient is now being followed-up and he is
in a good condition.
DISCUSSION
HA is a rare benign hepatic tumor [1], and there have
been only a few reports of HA in Koreans. The charac-
teristics of the reported cases are summarized in Table 1.
HA has been reported to usually regress after cessation of
hormonal stimulation [11]; however, it does have the
potential of malignant transformation. This might
represent an adenoma-carcinoma progression sequence
in hepatocarcinogenesis, which is similar to that seen for
colorectal cancer. However, such a transformation of HA
into HCC is very unusual because most HAs are resected
upon discovery. Therefore, only a few cases regarding
HCC arising in HA have been reported in the medical
literature. 
For most cases of HCC arising in HA, there is a
medication history of oral contraceptives or other anabolic
steroids [8-10] and in one previously reported case, a male
patient had a history of nephrotic syndrome that was
treated with oral prednisolone for 15 years [12]. However,
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Table 1.  The characteristics of the cases of hepatocellular adenomas reported in Korea
Reference sex Age Hormone Underlying Mass Echogenicity Enhancement/ Treatment Complication
(1
st author and year) (yr) history* disease number by sonography Density of CT
and size
Chung, et al., [18] 1987 male 34 N CHB 1 (7 cm) Not known E TACE and lobectomy N
Kim, et al., [19] 1990 male 24 N GSD** 6 (2-9 cm) E, Repeated TACE N
Kim, et al., [20] 1992 male 35 N CHB 1 (3 cm) E, Segmentectomy N
Kim, et al., [21] 1996 female 38 N N 1 (15 cm) NC E Lobectomy N
Kang, et al., [22] 1997 female 36 N N 1 (7.3 cm) E, Lobectomy N
Choi, et al., [23] 1998 male 42 N N 1 (8.5 cm) E, Lobectomy N
Choi, et al., [23] 1998 male 45 N N 1 (8 cm) E, Lobectomy N
Choi, et al., [23] 1998 male 40 N N 1 (6.2 cm) E, Lobectomy N
Kang, et al., [24] 2001 female 26 N N 1 (16 cm) E TACE → lobectomy N
*Male-anabolic steroid, Female-Oral contraceptives; **not confirmed; N, none; CHB, chronic hepatitis B; GSD, glycogen storge disease;
, Increased;    , Decreased;        , isoechoic; E,  enhanced; NC, not checked.
Figure 3. Macroscopic findings. The cut surface shows a well-
demarcated round, lobulated and dark reddish mass with a partly
hemorrhagic degenerated area, and the mass measured 4.5 cm in
diameter. A small round yellowish white nodule (arrow) is noted
within the mass, giving the pattern of a nodule within a nodule.it is interesting that the patient in our case hadn’t any risk
factors such as metabolic disease or a medication history,
including steroid hormone.
The clinical symptoms of HA include abdominal pain
and distension due to the presence of a mass, but in many
instances the tumor is asymptomatic and it is diagnosed
incidentally [4]. The liver function tests are generally
normal, but a slight elevation of serum transaminases or
alkaline phosphatase may be observed. AFP and PIVKA-II
is usually not elevated in adenoma, but the tumor markers
can be elevated for the cases of malignant transformation
[9]. In this present case, both the AFP and PIVKA-II
remained within the normal ranges.
The imaging modalities that are used for the diagnosis
of HA include abdominal ultrasound, CT and magnetic
resonance imaging. A percutaneous liver biopsy is
controversial because the histology is often non-diagnostic
and the procedure carries the risk of acute hemorrhage
[4,5,8,14]. Although HA is first detected by ultrasound in
many cases, the sonographic features are usually non-
specific and they may mimic other benign or malignant
hepatic lesions. Typically, contrast-enhanced CT scans
may show peripheral enhancement during the early phase
with subsequent centripetal flow during the portal venous
phase in adenoma; in the late phase, the lesion may
become isodense and then hypodense [14]. For the current
case, the CT findings are somewhat atypical; on the
arterial phase, the mass did not show peripheral enhance-
ment, but rather, it showed heterogenous enhancement.
On the portal and delayed phase, the lesion became iso-
dense or slightly enhanced. In particular, on the delayed
phase, some capsular portion of the mass appeared to
retain contrast material. This might be due to old intratu-
moral hemorrhage, necrosis or the fat contents. For the
pathologic finding, adenomas are composed of large
plates of liver cells, which are typically larger than normal
hepatocytes and they contain glycogen and lipid. The
nuclei are small and regular, and mitoses are seldom seen.
There is an absence of normal hepatic architecture and the
cells are arranged in normal or thickened trabeculae
interspersed with prominent arteries, thin walled blood
vessels and sinusoids [14].
Although factors such as chronic liver disease in male
patients or elevated tumor markers (AFP or PIVKA II)
strongly indicate that a hepatic neoplasm is malignant,
it is difficult to distinguish HA from well-differentiated
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Figure 4. Microscopic findings. (A) The liver cell cords are one to
two cells thick and the cell density is slightly increased compared to
the surrounding liver. Portal tracts are absent and focal steatosis is
noted (haematoxylin-eosin stain, ×100). (B) A low power microscopic
view reveals hepatocellular carcinoma (white arrow) arising in the
hepatocellular adenoma (haematoxylin-eosin stain, ×12.5). (C)
Microscopic findings of the hepatocelllular carcinoma area. Note the
typical trabecular features are more than three cell in thickness
(Edmondson-Steiner grade II), and pseudoacinar formation is also
noted (haematoxylin-eosin stain, ×200).
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CHCC only by examining small biopsied tissues and occa-
sionally even by examining the resected tumor specimens.
Recently, gene analysis is one of the useful methods for
distinguishing these tumors, although it is not practical as
an ordinary diagnostic procedure. Multiple chromosomal
aberrations detected by performing comparative genomic
hybridization (CGH), including gains or losses in one or
more than six chromosomes (1q, 4q, 8p, 8q, 16p and 19p),
have been reported in HCC, but not in HA [17].
Until now, an established treatment modality for HA
does not exist due to the small number of HA cases and
the small number of cases with HCC arising in HA. Some
investigators believe that that HA may regress over time,
especially after cessation of hormonal contraception in
females, and these researchers recommend resection only
for adenomas larger than 5 cm in diameter or for a tumor
that is increasing in size [11,25,26]. Yet other case reports
have described female patients with hepatocellular
adenoma that was confirmed by biopsy, and their tumor
didn’t regress after discontinuation of oral contraception,
but instead it progressed into HCC within 3 to 7 years of
follow-up. Furthermore, malignant transformation of HA
may occur without an increase of tumor size or increased
AFP levels. With this possibility of malignant transfor-
mation, there is also a high chance of rupture that can cause
bleeding and mortality. Therefore, many investigators
suggest that hepatic adenomas should be removed
regardless of their size [9,26].
In conclusion, our case suggests that HCC can develop
from HA in a non-cirrhotic male patient who was without
any risk factors for HCC. Therefore, complete resection of
HA might be required for properly treating this type of
tumor. 
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